Deborah F. Mason
384 Victoria St
Darlinghurst, NSW 2010, Australia
Darlinghurst, NSW 2010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Ethnic and socioeconomic dispensing patterns of disease-modifying therapies for multiple sclerosis in Aotearoa New Zealand.
Journal: Multiple sclerosis and related disorders
Published: April 01, 2025
Identifying multiple sclerosis in linked administrative health data in Aotearoa New Zealand.
Journal: The New Zealand medical journal
Published: March 27, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
Journal: NPJ digital medicine
Published: February 13, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2.
Journal: The Medical journal of Australia
Published: October 09, 2024
The evaluation of an osteoporosis medication management service in community pharmacy, a cohort study.
Journal: Exploratory research in clinical and social pharmacy
Published: June 23, 2024
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1.
Journal: The Medical journal of Australia
Published: April 25, 2024
The design and evaluation of a bone health teaching module for secondary school students in NSW, Australia.
Journal: Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals
Published: March 26, 2024
Osteoporosis screening in Australian community pharmacies: A mixed methods study.
Journal: Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals
Published: November 03, 2023
The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 04, 2023
Isolated leptomeningeal enhancement without cerebral microbleeds in biopsy-confirmed inflammatory cerebral amyloid angiopathy.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: October 02, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Journal: Brain : a journal of neurology
Published: August 08, 2023
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: November 07, 2021
Last Updated: 09/26/2026